Maria Shcherbakova, a neuroengineer specializing in brain-computer interfaces, a Stanford alumna, and currently a researcher at UC San Francisco. In 2024, with colleagues, she pioneered an adaptive Deep Brain Stimulation (aDBS) system for Parkinson’s disease, approved by the FDA this year. Her work has been published in Nature and featured in The New York Times.
These fluttering sensations are the brain’s reaction to certain emotions, which can be amplified or soothed by the gut’s own “bugs".
View this Issue
Olga Anczukow and Ryan Englander discuss how transcriptome splicing affects immune system function in lung cancer.
In our next roundtable webinar, learn how scientists leverage spatial biology to map tissues, uncover cellular interactions, and advance disease research.
Discover how scientists use the latest gene editing tools to advance health research.
Fujirebio's Lumipulse® G pTau217/β-Amyloid 1-42 Plasma Ratio test has the potential to shorten the Alzheimer's disease diagnostic journey and enable earlier intervention through its accessibility and high diagnostic performance.
Ten-year Agreement to Provide a Secure, AI-enabled Forensic Laboratory Information Management System Supporting DHS Forensic, Scientific, and Testing Services
deliver robust, reproducible solutions for sample preparation enabling a new era of end-to-end standardization in proteomics
Enables higher-throughput, cost effective single-cell sequencing
Enables ultra-low variant detection across a range of key MRD targets in AML, including very large FLT3-ITDs
